Screening Colonoscopy Changed to Diagnostic: How Should Physicians Bill the Claim?

A patient schedules a preventive screening colonoscopy. During the procedure, the physician finds a polyp and removes it, sometimes with a biopsy as well. The claim now involves therapeutic services, and the billing team has to decide on the right CPT codes, modifier, diagnosis order and patient cost-sharing. Get it wrong and the claim can deny, pay incorrectly or leave the patient with a bill they should not owe. The answer also depends on whether the payer is Original Medicare, a Medicare Advantage plan or a commercial plan, and the 2027 calendar year brings a Medicare cost-sharing change. This guide covers how screening colonoscopy changed to diagnostic should be handled.
Screening vs. diagnostic colonoscopy
Type | Purpose | Common billing considerations |
Screening | Preventive exam in an asymptomatic patient | Preventive service rules; screening diagnosis first |
Diagnostic | Investigates symptoms or abnormal findings | Diagnostic coding and payer policy |
Surveillance | Follow-up based on prior findings or history | Patient history and coverage rules; often a high-risk benefit |
Therapeutic | Treatment such as polyp removal | Procedure-specific CPT reporting |
Evaluate both the clinical indication and the services actually performed. Finding or removing a polyp does not by itself erase the preventive nature of the encounter; payers simply handle the conversion differently.
When does a screening colonoscopy become diagnostic?
• A polyp is found and removed, or a biopsy is taken.
• An abnormal lesion needs further evaluation or another intervention.
• Clinical circumstances change from the original screening plan.
Does polyp removal change the classification? Original Medicare: when a planned screening converts, you report the diagnostic or therapeutic CPT code with modifier PT. The deductible is waived, but a reduced coinsurance applies. Commercial plans: federal ACA guidance generally treats polyp removal during a screening as part of the preventive service, so plans typically bill it without cost-sharing, often with modifier 33. Payers vary, so verify each policy. |
Which CPT codes should billing teams review?
Code | General description (paraphrased; confirm in the current AMA CPT code set) |
45378 | Diagnostic colonoscopy |
45380 | Colonoscopy with biopsy |
45381 | Colonoscopy with directed submucosal injection |
45382 | Colonoscopy with control of bleeding |
45384 | Removal of lesion by hot biopsy forceps |
45385 | Removal of lesion by snare technique |
45386 | Colonoscopy with balloon dilation |
45388 | Colonoscopy with ablation of lesion |
G0121 / G0105 / G0104 | Medicare screening: G0121 colonoscopy not high risk, G0105 colonoscopy high risk, G0104 flexible sigmoidoscopy |
Report what was actually performed and documented. Colonoscopy codes belong to an endoscopic family, so payers apply multiple-endoscopy and NCCI rules. When different lesions are treated by different techniques, some payers require modifier 59 or an X modifier, but only when the record shows distinct lesions. Not every service is separately billable. Check code-year changes each January.
Modifier PT vs. modifier 33
Modifier PT (Medicare) Identifies a colorectal cancer screening test converted to a diagnostic test or other procedure. Append it to at least one code on the claim. Deductible waived; reduced coinsurance applies. | Modifier 33 (preventive) Identifies a preventive service under ACA rules used by many commercial payers. Verify that the payer recognizes it and how it processes the conversion. |
The two are not interchangeable and should not be added together automatically. Using PT on a commercial claim, or 33 on a Medicare claim, is a common error.
Medicare billing rules when screening becomes diagnostic
Dates of service | Beneficiary coinsurance (PT claims) | Deductible |
CY 2023 through 2026 | 15% | Waived |
CY 2027 through 2029 | 10% | Waived |
CY 2030 and later | No coinsurance | Waived |
Per CMS (claims processing manual transmittal) and Noridian, the coinsurance falls from 15% to 10% for 2027 dates of service. Anesthesia for a converted case is reported with 00811 and modifier PT, and moderate sedation uses PT only. A colonoscopy after a positive stool-based test is a separate flexibility billed as screening with modifier KX. Medicare Advantage plans have their own cost-sharing and processes; check each plan. Confirm all amounts for the date of service.
Real-world billing scenarios (illustrative)
| 1. No findings | 2. Polyp removed | 3. Symptom-driven |
Situation | Asymptomatic screening; normal exam | Screening; snare removal of a polyp | Colonoscopy ordered for documented symptoms |
Coding | Medicare: G0121 or G0105; commercial: 45378 per payer | Therapeutic CPT (e.g., 45385) for what was done | Diagnostic or therapeutic CPT per findings |
Modifiers | Commercial: 33 if payer requires | Medicare: PT; commercial: 33 per payer | Neither PT nor 33; it was never a screening |
Diagnosis | Screening code first | Screening code first, finding second | Symptom or finding code |
Mistake to avoid | Billing it as diagnostic | Wrong modifier for the payer | Billing a symptomatic exam as preventive |
Documentation requirements for physicians
☐ Original indication for the colonoscopy ☐ Symptoms or absence of symptoms ☐ Relevant medical history ☐ Prior colonoscopy findings ☐ Physician’s operative report ☐ Polyp location and removal technique | ☐ Biopsy or pathology documentation ☐ Correct CPT code selection ☐ Appropriate ICD-10-CM diagnosis coding ☐ Applicable modifiers ☐ Payer-specific billing requirements ☐ Patient cost-sharing considerations |
Click the boxes in Word. The record must support every service and the indication reported on the claim.
Common colonoscopy billing mistakes that lead to denials
Billing mistake | Potential consequence | Recommended prevention |
Incorrect screening classification | Claim processing problems | Review the original indication |
Missing applicable modifier | Wrong preventive benefit processing | Validate payer rules |
Incorrect CPT selection | Denial or payment discrepancy | Match code to procedure |
Incomplete operative report | Records requests or denials | Review physician documentation |
Incorrect diagnosis association | Medical necessity issues | Verify diagnosis support |
Ignoring payer policies | Reimbursement delays | Check payer guidelines |
Incorrect patient responsibility | Compliance concerns | Validate coverage rules |
Not every denial has the same cause, so correct the actual issue.
How billing teams can improve colonoscopy claim accuracy
1 Verify the original indication | 2 Review the operative report | 3 Identify all services performed | 4 Confirm CPT and ICD-10-CM codes | 5 Review modifier requirements |
6 Check Medicare or commercial policy | 7 Validate patient cost-sharing | 8 Scrub the claim before submission | 9 Monitor adjudication and denials | 10 Review recurring issues |
How Sirius Solutions Global supports gastroenterology billing
The Sirius Solutions Global website lists medical coding, claims review, eligibility verification, denial management, prior authorization, credentialing, medical billing audit and A/R follow-up services, using AI-assisted checks with human verification. For colonoscopy billing, that maps to coding accuracy, claim edits, preventive service classification, modifier review, denial prevention and reimbursement monitoring. We do not claim gastroenterology-specific results or guarantee reimbursement. You focus on patient care. We’ll handle the rest.
How strong is your colonoscopy billing workflow?
Question | Yes | No |
Are screening and diagnostic indications reviewed before claim submission? | ☐ | ☐ |
Are operative reports checked against billed CPT codes? | ☐ | ☐ |
Are modifiers PT and 33 applied according to payer requirements? | ☐ | ☐ |
Are preventive service policies reviewed regularly? | ☐ | ☐ |
Are claim denials categorized by root cause? | ☐ | ☐ |
Is patient cost-sharing reviewed before statements are generated? | ☐ | ☐ |
Yes answers | What it suggests |
0–2 | Your workflow may need a closer review |
3–4 | Consider strengthening coding and claim review processes |
5–6 | Maintain regular monitoring and compliance reviews |
Count your Yes answers. Not a compliance certification or guarantee.
Frequently asked questions
Q: What happens when a screening colonoscopy becomes diagnostic? The claim reports what was actually done. Medicare uses the diagnostic or therapeutic CPT code with modifier PT; commercial plans often use modifier 33 and their own preventive rules. |
Q: Does removing a polyp change a screening to diagnostic? It changes how the services are coded and, for Medicare, cost-shared. It does not erase the screening indication, so report the screening diagnosis first. |
Q: What CPT code is used when a polyp is removed? It depends on the technique, such as 45385 for snare or 45384 for hot biopsy forceps. Code from the operative report. |
Q: What is modifier PT? A Medicare modifier for a colorectal cancer screening test converted to a diagnostic test or other procedure. |
Q: What is the difference between PT and 33? PT is the Medicare conversion modifier; 33 identifies preventive services under ACA-based commercial rules. They are not interchangeable. |
Q: Does Medicare cover polyp removal during screening? Yes. The deductible is waived and a reduced coinsurance applies. |
Under Original Medicare, yes: 15% for 2026 dates of service and 10% for 2027 through 2029. Commercial and Medicare Advantage rules vary. |
Q: How should a diagnostic colonoscopy be billed? With the CPT code for the service performed and a diagnosis for the symptom or finding. PT and 33 do not apply. |
Q: What documentation is required? Indication, history, operative report, lesion details, pathology and the codes and diagnoses supported by them. |
Q: Why are colonoscopy claims denied? Common causes are the wrong modifier, wrong screening classification, CPT mismatch, thin documentation and payer-policy errors. |
Q: Does screening need a different diagnosis code from diagnostic? Screening claims use a screening code (such as Z12.11) first-listed; a converted claim keeps it first with the finding second. A symptomatic exam uses a symptom or finding code. |
Disclaimer For general information only; not legal, coding, compliance or financial advice. CPT descriptions are paraphrased; consult the current AMA CPT code set. Medicare and payer rules change, and this guide reflects sources reviewed November 11, 2026. Original Medicare, Medicare Advantage and commercial plans differ; verify each payer’s policy before billing. Sirius Solutions Global does not guarantee reimbursement or compliance. To request a correction, email Info@siriussolutionsglobal.com. |





